Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongxin Han

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|April 7, 2004
A caspase active site probe reveals high fractional inhibition needed to block DNA fragmentationNathalie Méthot, John P Vaillancourt, JingQi Huang, et al.
Nature Genetics|January 30, 2007
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasisSofi G Julien, Nadia Dubé, Michelle Read, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritisPatsy Clark, Steven E Rowland, Danielle Denis, et al.
European Journal of Immunology|May 29, 2008
Mutual antagonistic relationship between prostaglandin E(2) and IFN-gamma: Implications for rheumatoid arthritisMarie-Claude Mathieu, Simon Lord-Dufour, Virginie Bernier, et al.
Experimental Cell Research|July 17, 2007
The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cellsDurga Prasad Cherukuri, Xiao B O Chen, Anne-Christine Goulet, et al.
The Journal of Experimental Medicine|January 14, 2004
Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeuticsNathalie Méthot, JingQi Huang, Nathalie Coulombe, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case StudyAlexander S Rich, Yvonne H Chan, Benjamin Birnbaum, et al.
Journal of Cellular Physiology|August 9, 2021
WNT5B promotes vascular smooth muscle cell dedifferentiation via mitochondrial dynamics regulation in chronic thromboembolic pulmonary hypertensionFeng Wang, Yanan Zhen, Chaozeng Si, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitorsYongxin Han, André Giroux, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2010
A novel series of potent and selective EP(4) receptor ligands: facile modulation of agonism and antagonismMichael J Boyd, Carl Berthelette, Jean-François Chiasson, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|April 7, 2004
A caspase active site probe reveals high fractional inhibition needed to block DNA fragmentationNathalie Méthot, John P Vaillancourt, JingQi Huang, et al.
Nature Genetics|January 30, 2007
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasisSofi G Julien, Nadia Dubé, Michelle Read, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritisPatsy Clark, Steven E Rowland, Danielle Denis, et al.
European Journal of Immunology|May 29, 2008
Mutual antagonistic relationship between prostaglandin E(2) and IFN-gamma: Implications for rheumatoid arthritisMarie-Claude Mathieu, Simon Lord-Dufour, Virginie Bernier, et al.
Experimental Cell Research|July 17, 2007
The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cellsDurga Prasad Cherukuri, Xiao B O Chen, Anne-Christine Goulet, et al.
The Journal of Experimental Medicine|January 14, 2004
Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeuticsNathalie Méthot, JingQi Huang, Nathalie Coulombe, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case StudyAlexander S Rich, Yvonne H Chan, Benjamin Birnbaum, et al.
Journal of Cellular Physiology|August 9, 2021
WNT5B promotes vascular smooth muscle cell dedifferentiation via mitochondrial dynamics regulation in chronic thromboembolic pulmonary hypertensionFeng Wang, Yanan Zhen, Chaozeng Si, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitorsYongxin Han, André Giroux, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2010
A novel series of potent and selective EP(4) receptor ligands: facile modulation of agonism and antagonismMichael J Boyd, Carl Berthelette, Jean-François Chiasson, et al.
Pageof 7